Home/PeptiDream/Patrick C. Reid
PC

Patrick C. Reid

Director, Executive Officer (Business Development)

PeptiDream

PeptiDream Pipeline

DrugIndicationPhase
PD-1/IL-2Solid TumorsPhase 1/2
PPS-001Undisclosed OncologyPreclinical
177Lu-PNT6555 (w/ Novartis)Small Cell Lung Cancer (DLL3+)Phase 1